Article
Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
Rheumatology international - 1 Oct 2017
Nair Aswin M, Goel Ruchika, Hindhumati M, Jayakanthan K, Visalakshi J, Joseph George, Danda Sumita, Danda Debashish
Abstract excerpt
Assessment of disease activity in Takayasu arteritis (TA) is challenging. We aimed to study utility of serum amyloid A (SAA) to assess disease activity and its association with SAA gene polymorphisms, if any, in our TA patients. Serum of 99 consecutive adult TA patients and 40 healthy controls were assayed for SAA. Depending on the ITAS2010 and ITAS-CRP score, patients were designated as having active disease if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.